MX2010001079A - Derivados de 1-oxo-isoindolina-4-carboxamidas y de 1-oxo-1,2,3,4-tetrahidroisoquinoleina-5-carboxamidas, su preparacion y su aplicacion en terapeutica. - Google Patents
Derivados de 1-oxo-isoindolina-4-carboxamidas y de 1-oxo-1,2,3,4-tetrahidroisoquinoleina-5-carboxamidas, su preparacion y su aplicacion en terapeutica.Info
- Publication number
- MX2010001079A MX2010001079A MX2010001079A MX2010001079A MX2010001079A MX 2010001079 A MX2010001079 A MX 2010001079A MX 2010001079 A MX2010001079 A MX 2010001079A MX 2010001079 A MX2010001079 A MX 2010001079A MX 2010001079 A MX2010001079 A MX 2010001079A
- Authority
- MX
- Mexico
- Prior art keywords
- oxo
- alkyl
- carboxamide
- isoindoline
- nr7r8
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Abstract
La invención se refiere a los derivados de 1-oxo-isoindolina-4-car boxamidas y de 1-oxo-1,2,3,4-tetrahidroisoquinoleina-5-carboxamida s, de fórmula general (I) en la que R1 representa un átomo de hidrógeno, un grupo alquilo(C1-C6), cicloalquilo(C3-C7) (CH2)n-alquenilo(C1-C6), (CH2)n-alquinilo(C1-C6), alquilo(C1-C6)-Z-alquilo(C1-C6) en el que Z representa un heteroátomo elegido entre O, N y S(O)m, o bien R1 representa un grupo COOR, S(O)mR, un arilo o un aralquilo; R2 representa uno o varios grupos elegidos entre un átomo de hidrógeno, un átomo de halógeno, un grupo alquilo(C1-C6), cicloalquilo(C3-C7), alquenilo(C1-C6), alquinilo(C1-C5), alquilo(C1-C6)-Z-alquilo(C1-C6 ), en el que z representa un heteroátomo elegido entre O, N y S(O)m, o bien R2 representa un grupo haloalquilo(C1-C6), haloalcoxi(C1-C6), hidroxi, alcoxi(C1-C6), nitro, ciano, amino un grupo NR7R8, COOR, CONR7R8, OCOalquilo(C1-C6), S(O)mNR7R8, un grupo arilo, R3 representa un grupo trifluorometilo; R4 y R5 representan, independientemente uno del otro un átomo de hidrógeno, o bien R4 y R5 forman con el átomo de carbono que los llevan un ciclo saturado que contiene de 3 a 6 átomos de carbono y que contiene opcionalmente de O a 1 heteroátomos elegidos entre O, N o S; R6 representa un grupo elegido entre un átomo de hidrógeno, un átomo de halógeno, un grupo alquilo(C1-C5), cicloalquilo(C3-C7), cicloalquilo(C3-C7)-alquilo(C3-C6), un grupo haloalquilo(C1-C6), nitro, amino, un grupo NR7R8, COOR, un grupo NR7(SO2)R8, CONR7R8, un grupo arilo o heterociclo; X representa un grupo alquileno(C1-C2); m representa un número entero comprendido O y n representa un número entero comprendido entre 1y 6. La invención tiene igualmente por objeto un procedimiento de preparación y su aplicación en terapéutica como inhibidores de ß-secretasa para tratar los trastornos neurodegenerativos tales como Alzheimer.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0705499A FR2919285B1 (fr) | 2007-07-27 | 2007-07-27 | Derives de 1-oxo-isoindoline-4-carboxamides et de 1-oxo- 1,2,3,4-tetrahydroisoquinoleine-5-carboxamides, leur preparation et leur application en therapeutique. |
| PCT/FR2008/001110 WO2009044019A2 (fr) | 2007-07-27 | 2008-07-25 | Dérivés de 1-oxo-isoindoline-4-carboxamides et de 1-oxo-1,2,3,4-tetrahydroisoquinoleine-5-carboxamides, leur préparation et leur application en thérapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2010001079A true MX2010001079A (es) | 2010-03-24 |
Family
ID=39092246
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2010001079A MX2010001079A (es) | 2007-07-27 | 2008-07-25 | Derivados de 1-oxo-isoindolina-4-carboxamidas y de 1-oxo-1,2,3,4-tetrahidroisoquinoleina-5-carboxamidas, su preparacion y su aplicacion en terapeutica. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US8372864B2 (es) |
| EP (1) | EP2185511A2 (es) |
| JP (1) | JP5412428B2 (es) |
| KR (1) | KR20100051830A (es) |
| CN (1) | CN101790514B (es) |
| AU (1) | AU2008306763B2 (es) |
| BR (1) | BRPI0813624A2 (es) |
| CA (1) | CA2694322A1 (es) |
| CO (1) | CO6290678A2 (es) |
| EA (1) | EA201070197A1 (es) |
| FR (1) | FR2919285B1 (es) |
| HK (1) | HK1143163A1 (es) |
| MA (1) | MA31635B1 (es) |
| MX (1) | MX2010001079A (es) |
| MY (1) | MY150436A (es) |
| NZ (1) | NZ582873A (es) |
| SG (1) | SG183082A1 (es) |
| WO (1) | WO2009044019A2 (es) |
| ZA (1) | ZA201000582B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2729007A1 (de) | 2011-07-04 | 2014-05-14 | Bayer Intellectual Property GmbH | Verwendung substituierter isochinolinone, isochinolindione, isochinolintrione und dihydroisochinolinone oder jeweils deren salze als wirkstoffe gegen abiotischen pflanzenstress |
| CN105254554B (zh) * | 2014-07-14 | 2018-01-30 | 南开大学 | 一种制备异吲哚啉酮类化合物的方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997008164A1 (en) * | 1995-08-25 | 1997-03-06 | E.I. Du Pont De Nemours And Company | Bicyclic herbicides |
| DE10018449A1 (de) | 2000-04-14 | 2001-11-22 | Top Caredent Ag Zuerich | Vorrichtung zum Darbieten von Gerätschaften der Dentalhygiene |
| AU2002359376B2 (en) * | 2001-11-08 | 2008-01-10 | Elan Pharmaceuticals, Inc. | N, N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| GB0228410D0 (en) * | 2002-12-05 | 2003-01-08 | Glaxo Group Ltd | Novel Compounds |
| GB0305918D0 (en) * | 2003-03-14 | 2003-04-23 | Glaxo Group Ltd | Novel compounds |
| GB0309221D0 (en) | 2003-04-23 | 2003-06-04 | Glaxo Group Ltd | Novel compounds |
| GB0328900D0 (en) | 2003-12-12 | 2004-01-14 | Glaxo Group Ltd | Novel compounds |
| US7745470B2 (en) | 2005-03-10 | 2010-06-29 | Bristol-Myers Squibb Company | Isophthalates as beta-secretase inhibitors |
| GB0506562D0 (en) | 2005-03-31 | 2005-05-04 | Glaxo Group Ltd | Novel compounds |
| CA2694288A1 (fr) * | 2007-07-27 | 2009-04-09 | Sanofi-Aventis | Derives de 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamides et de 2,3,4,5-tetrahydropyrrolo[1,2-a][1,4]-diazepine-7-carboxamides, leur preparation et leur application en therapeutique |
| FR2919286A1 (fr) * | 2007-07-27 | 2009-01-30 | Sanofi Aventis Sa | Derives de derives de 1-oxo-1,2-dihydroisoquinoleine-5- carboxamides et de 4-oxo-3,4-dihydroquinazoline-8- carboxamides,leur preparation et leur application en therapeutique. |
-
2007
- 2007-07-27 FR FR0705499A patent/FR2919285B1/fr not_active Expired - Fee Related
-
2008
- 2008-07-25 JP JP2010517453A patent/JP5412428B2/ja not_active Expired - Fee Related
- 2008-07-25 WO PCT/FR2008/001110 patent/WO2009044019A2/fr active Application Filing
- 2008-07-25 EP EP08835551A patent/EP2185511A2/fr not_active Ceased
- 2008-07-25 NZ NZ582873A patent/NZ582873A/en not_active IP Right Cessation
- 2008-07-25 KR KR1020107004339A patent/KR20100051830A/ko not_active Application Discontinuation
- 2008-07-25 CN CN2008801045290A patent/CN101790514B/zh not_active Expired - Fee Related
- 2008-07-25 BR BRPI0813624A patent/BRPI0813624A2/pt not_active IP Right Cessation
- 2008-07-25 CA CA2694322A patent/CA2694322A1/fr not_active Abandoned
- 2008-07-25 MY MYPI20100428 patent/MY150436A/en unknown
- 2008-07-25 SG SG2012055539A patent/SG183082A1/en unknown
- 2008-07-25 MX MX2010001079A patent/MX2010001079A/es active IP Right Grant
- 2008-07-25 AU AU2008306763A patent/AU2008306763B2/en not_active Ceased
- 2008-07-25 EA EA201070197A patent/EA201070197A1/ru unknown
-
2010
- 2010-01-26 CO CO10007698A patent/CO6290678A2/es not_active Application Discontinuation
- 2010-01-26 US US12/693,597 patent/US8372864B2/en not_active Expired - Fee Related
- 2010-01-26 ZA ZA2010/00582A patent/ZA201000582B/en unknown
- 2010-02-24 MA MA32652A patent/MA31635B1/fr unknown
- 2010-10-15 HK HK10109764.3A patent/HK1143163A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2694322A1 (fr) | 2009-04-09 |
| AU2008306763A1 (en) | 2009-04-09 |
| NZ582873A (en) | 2012-07-27 |
| US8372864B2 (en) | 2013-02-12 |
| HK1143163A1 (es) | 2010-12-24 |
| CN101790514A (zh) | 2010-07-28 |
| WO2009044019A9 (fr) | 2010-10-14 |
| FR2919285A1 (fr) | 2009-01-30 |
| JP2010534641A (ja) | 2010-11-11 |
| EA201070197A1 (ru) | 2010-08-30 |
| KR20100051830A (ko) | 2010-05-18 |
| MA31635B1 (fr) | 2010-08-02 |
| AU2008306763B2 (en) | 2013-08-29 |
| SG183082A1 (en) | 2012-08-30 |
| WO2009044019A3 (fr) | 2009-06-18 |
| EP2185511A2 (fr) | 2010-05-19 |
| JP5412428B2 (ja) | 2014-02-12 |
| CN101790514B (zh) | 2012-12-19 |
| MY150436A (en) | 2014-01-30 |
| CO6290678A2 (es) | 2011-06-20 |
| FR2919285B1 (fr) | 2012-08-31 |
| ZA201000582B (en) | 2011-04-28 |
| BRPI0813624A2 (pt) | 2019-09-24 |
| US20100197725A1 (en) | 2010-08-05 |
| WO2009044019A2 (fr) | 2009-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2572189T3 (es) | Derivados de 2,3-dihidroimidazo[1,2-c]quinazolina sustituidos de utilidad en el tratamiento de trastornos hiperproliferativos y enfermedades asociadas con la angiogénesis | |
| ATE513546T1 (de) | Imidazolidin-derivate, ihre verwendungen, ihre zubereitung und diese enthaltende zusammensetzungen | |
| NZ596579A (en) | Bace inhibitors | |
| EA200702058A1 (ru) | Новые фармацевтические соединения | |
| AR079327A1 (es) | Derivados de 2-amino-5,5-difluor -5,6-dihidro-4h-(1,3) oxazin-4-il) fenil)-amida | |
| MX2009011212A (es) | Derivados de triazolopiridina carboxamida y triazolopirimidina carboxamida, su preparacion y su aplicacion terapeutica. | |
| EA200970461A1 (ru) | ЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ 3-ИЗОБУТИЛ-9,10-ДИМЕТОКСИ-1,3,4,6,7,11b-ГЕКСАГИДРО-2Н-ПИРИДО[2,1-a]ИЗОХИНОЛИН-2-ОЛА И СВЯЗАННЫЕ С НИМИ СПОСОБЫ | |
| AR074002A1 (es) | Pirazolo e imidazopiridinilpirimidinaminas como inhibidores de la tirosina kinasa (igr-ir) | |
| AR047683A1 (es) | Pirazoles para el tratamiento de obesidad y trastornos psiquiatricos | |
| HUP0301573A2 (hu) | Szubsztituált arilpirazinok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| UA72917C2 (en) | Cyclic carbamates derivatives, pharmaceutical composition containing said derivatives of cyclic carbamates and active ingredients as modulators of the progesterone receptor | |
| MY146494A (en) | Indole sulfonamide modulators of progesterone receptors | |
| HUP0303281A2 (hu) | Benzodiazepinszármazékok, mint GABA A receptor modulátorok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| NO20092286L (no) | Nitrogenhaldige heterosykliske forbindelser og anvendelse derav | |
| MX2010006202A (es) | Derivados de oxindol substituidos por amidometil y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina. | |
| PE20090477A1 (es) | Derivados de oxazol como inhibidores de los canales de sodio | |
| MX2010001076A (es) | Derivados de 1,2,3,4-tetrahidropirrolo-[1,2-a]-pirazina-6-carboxam ida y 2,3,4,5-tetrahidropirrollo [1,2,a] [1,4]-diazepina-7-carboxa mida, preparacion y su uso terapeutico. | |
| MXPA05005146A (es) | Indolpiridinio sustituido como compuestos antiinfecciosos. | |
| AR047958A1 (es) | Derivados de 1-bencil-5-piperazin-1-il-3,4 dihidro-1h-quinazolin-2-ona y sus derivados 1h-benzo(1,2,6)tiadiazina-2,2-dioxidos y 1,4-dihidro-benzo(d)(1,3)oxazinas-2-ona,como moduladores del receptor 5-ht,para el tratamiento de enfermedades del sistema nervioso central. | |
| DK1756095T3 (da) | Cyanopyrrolholdige cycliske carbamat- og thiocarbamatbiaryler og fremgangsmåder til fremstilling heraf | |
| CY1116391T1 (el) | Αιθινυλο παραγωγα ως θετικοι αλλοστερικοι ρυθμιστες του mglur5 | |
| AR067057A1 (es) | Oxazolidinonas sustituidas y su uso | |
| ATE535241T1 (de) | Verwendung von 3-(indolyl)- oder 3-(azaindolyl)-4-arylmaleimid-derivaten bei der behandlung von leukämie | |
| RU2010107603A (ru) | Производные n-(2-тиазолил)амида для лечения ожирения, диабетов и сердечно-сосудистых заболеваний | |
| MX2010001079A (es) | Derivados de 1-oxo-isoindolina-4-carboxamidas y de 1-oxo-1,2,3,4-tetrahidroisoquinoleina-5-carboxamidas, su preparacion y su aplicacion en terapeutica. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |